A Systematic Review on the Epidemiology of Pediatric Burn in Iran

Sayed Saeed Hashemi1, Asaad Sharhani, Bahare Lotfi

  • 1From the *Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran; and †Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi Hospitals, Kermanshah University of Medical Sciences, Iran.

Insights

Pediatric burns are a global concern, with hot liquids being the most common cause in Iranian children under 15. Male children and urban areas show higher incidence rates, emphasizing the need for targeted prevention strategies.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Burns represent a significant global health challenge, particularly among children.
  • Understanding the epidemiology of pediatric burns is crucial for developing effective prevention strategies.

Purpose of the Study:

  • To systematically review and analyze the epidemiology of burn injuries in Iranian children under 15 years old.
  • To identify key risk factors, causes, and outcomes associated with pediatric burns in Iran.

Main Methods:

  • A systematic review of studies published before 2016 was conducted.
  • Relevant articles were retrieved from major scientific databases using specific keywords.
  • The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist was used for quality assessment of the included studies.

Main Results:

  • Thirty-five relevant studies were evaluated, indicating a higher incidence of burns in male pediatric patients (9.5 to 50 per 100,000 children).
  • The mortality rate for pediatric burns ranged from 1.7% to 18.5%.
  • Hot water/liquids were the most frequent cause, with burns predominantly occurring in urban homes.

Conclusions:

  • Pediatric burn injuries are a major public health issue in Iran, particularly affecting younger males.
  • Prevention efforts should focus on home safety and specific interventions for high-risk demographics.
  • Further research is needed to reduce the incidence and mortality of pediatric burns.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
303
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
503
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
398
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
664